Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation, 13785-13786 [2021-04946]

Download as PDF Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices public in accordance with the provisions of 5 U.S.C. 552, will be available for website viewing and printing in the Commission’s Public Reference Room, 100 F Street NE, Washington, DC 20549, on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of such filing also will be available for inspection and copying at the principal office of FINRA. All comments received will be posted without change. Persons submitting comments are cautioned that we do not redact or edit personal identifying information from comment submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File No. SR–FINRA–2020–041 and should be submitted on or before March 24, 2021. If comments are received, any rebuttal comments should be submitted on or before March 31, 2021. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.75 J. Matthew DeLesDernier, Assistant Secretary. [FR Doc. 2021–04912 Filed 3–9–21; 8:45 am] BILLING CODE 8011–01–P DEPARTMENT OF STATE [Public Notice: 11373] Notice of Public Meeting The Department of State will conduct a public meeting at 9:30 a.m. on Tuesday, April 6, 2021, by way of teleconference. Members of the public may participate up to the capacity of the teleconference phone line, which will handle 500 participants. To access the teleconference line, participants should call (804) 469–0625 and use participant Code 974556036#. The primary purpose of the meeting is to prepare for the 8th session of the International Maritime Organization’s (IMO) Sub-Committee on Navigation, Communication, and Search and Rescue to be held remotely, April 19–23, 2021. The agenda items to be considered include: —Adoption of the agenda —Decisions of other IMO bodies —Routing measures and mandatory ship reporting systems —Recognition of the Japanese regional navigation satellite system QuasiZenith Satellite System (QZSS) and development of performance 75 17 CFR 200.30–3(a)(12); 17 CFR 200.30– 3(a)(57). VerDate Sep<11>2014 17:22 Mar 09, 2021 Jkt 253001 standards for shipborne satellite navigation system receiver equipment —Safety measures for non-SOLAS ships operating in polar waters —Revision of SOLAS chapters III and IV for Modernization of the GMDSS, including related and consequential amendments to other existing instruments —Response to matters related to the ITU–R Study Groups and ITU World Radiocommunication Conference —Revision of the Guidelines on places of refuge for ships in need of assistance (resolution A.949(23)) —Developments in GMDSS services, including guidelines on Maritime safety information (MSI) —Development of global maritime SAR services, including harmonization of maritime and aeronautical procedures —Biennial status report and provisional agenda for NCSR 9 —Election of Chair and Vice-Chair for 2022 —Any other business Please note: The Sub-Committee may on short notice, adjust the NCSR 8 agenda to accommodate the constraints associated with the virtual meeting format. Any updates will be provided at the public meeting and in advance, if possible, to anyone who RSVPs. Those who plan to participate may contact the meeting coordinator, George Detweiler, by email at George.H.Detweiler@uscg.mil, by phone at (202) 372–1566, or in writing at 2703 Martin Luther King Jr. Ave. SE, Stop 7418, Washington, DC 20593–7418. A request for reasonable accommodation should be made at the time of RSVP, and not later than April 30. Requests received after that date will be considered, but might not be possible to fulfill. Jeremy M. Greenwood, Coast Guard Liaison Officer, Office of Ocean and Polar Affairs, Department of State. [FR Doc. 2021–04982 Filed 3–9–21; 8:45 am] BILLING CODE 4710–09–P DEPARTMENT OF STATE [Public Notice: 11372] Convening of an Accountability Review Board To Investigate the Murder of an Animal and Plant Health Inspection Service (APHIS) Locally Employed (LE) Staff Member in Tijuana, Mexico Pursuant to Section 301 of the Omnibus Diplomatic Security and Antiterrorism Act of 1986, as amended (22 U.S.C. 4831), the Department of State convened an Accountability PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 13785 Review Board (ARB) to review the October 2020 murder of an APHIS LE Staff member in Tijuana, Mexico. The ARB will examine the facts and circumstances surrounding the incident and submit its findings to the Secretary of State, together with any recommendations as appropriate. The Department has appointed George Staples, a retired U.S. ambassador, as Chair of the Board. The other Board members are retired U.S. Ambassador Janice Jacobs, Mr. Dirk Dijkerman, Mr. John Eustace, and Mr. Kimber Davidson. They bring to their deliberations distinguished backgrounds in government service. The Board will submit its findings and recommendations to the Secretary of State. The Department will report to Congress on any recommendations made by the Board and actions taken with respect to those recommendations. Anyone with information relevant to the Board’s examination of these incidents should contact the Board via email promptly at ARBTijuana2021@ state.gov. Zachary A. Parker, Director, Office of Directives Management. [FR Doc. 2021–05004 Filed 3–9–21; 8:45 am] BILLING CODE 4710–10–P OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE Notice of Product Exclusion Extensions: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation Office of the United States Trade Representative (USTR). ACTION: Notice. AGENCY: In prior notices, the U.S. Trade Representative modified the action in the Section 301 investigation of China’s acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address the COVID–19 pandemic. To support efforts to combat COVID–19, on December 29, 2020, the U.S. Trade Representative announced the extension of certain product exclusions on medical-care and/or COVID response products and further modifications to remove Section 301 duties from additional medical-care and/or COVID response products. This notice announces the U.S. Trade Representative’s determination to extend those exclusions. SUMMARY: E:\FR\FM\10MRN1.SGM 10MRN1 13786 Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices The extensions announced in this notice will extend the product exclusions through September 30, 2021. U.S. Customs and Border Protection will issue instructions on entry guidance and implementation. FOR FURTHER INFORMATION CONTACT: For general questions about this notice, contact Associate General Counsel Philip Butler, Assistant General Counsels Benjamin Allen or Susie Park Hodge, or Director of Industrial Goods Justin Hoffmann at (202) 395–5725. For specific questions on customs classification or implementation of the product exclusions identified in the Annexes to this notice, contact traderemedy@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: DATES: A. Background In the course of this investigation the U.S. Trade Representative has imposed additional duties on products of China in four tranches. See 83 FR 28719 (June 20, 2018); 83 FR 40823 (August 16, 2018); 83 FR 47974 (September 21, 2018), as modified by 83 FR 49153 (September 28, 2018); and 84 FR 43304 (August 20, 2019), as modified by 84 FR 69447 (December 18, 2019) and 85 FR 3741 (January 22, 2020). For each tranche, the U.S. Trade Representative established a process by which U.S. stakeholders could request the exclusion of particular products subject to the action. The U.S. Trade Representative later established a process by which U.S. stakeholders could request the extension of particular exclusions. Additionally, on March 25, 2020, the U.S. Trade Representative requested public comments on possible further modifications to remove Section 301 duties from additional medical-care products to address the COVID–19 pandemic. 85 FR 16987 (March 25, 2020). In light of the evolving nature of the battle against COVID–19, on December 29, 2020, USTR announced the extension of 80 product exclusions on medical-care and/or COVID response products; further modifications in the form of 19 product exclusions to remove Section 301 duties from additional medical-care and/or COVID response products; and that USTR might consider further extensions and/or modifications as appropriate. See 85 FR 85831 (the December 29 notice). B. Determination To Extend Certain Exclusions In light of the continuing efforts to combat COVID–19, the U.S. Trade Representative has determined that it is inappropriate to allow the exclusions VerDate Sep<11>2014 17:22 Mar 09, 2021 Jkt 253001 for certain products to lapse. Accordingly, pursuant to sections 301(b), 301(c), and 307(a) of the Trade Act of 1974, as amended, the U.S. Trade Representative has determined to extend the 99 product exclusions included in the December 29 notice through September 30, 2021, as specified in the Annex to this notice. The U.S. Trade Representative’s decision to extend the 99 product exclusions takes into account public comments previously provided, and the advice of advisory committees the interagency Section 301 Committee. As provided in the December 29 notice, the exclusions are available for any product that meets the description in the product exclusion. The U.S. Trade Representative may continue to consider further extensions and/or additional modifications as appropriate. Annex Effective with respect to goods entered for consumption, or withdrawn from warehouse for consumption, on or after 12:01 a.m. eastern daylight time on April 1, 2021, and before 11:59 p.m. eastern daylight time on September 30, 2021, each of the article descriptions of headings 9903.88.62, 9903.88.63, 9903.88.64 and 9903.88.65 of the Harmonized Tariff Schedule of the United States are modified by deleting ‘‘March 31, 2021,’’ and by inserting ‘‘September 30, 2021,’’ in lieu thereof. Greta Peisch, General Counsel, Office of the United States Trade Representative. [FR Doc. 2021–04946 Filed 3–9–21; 8:45 am] BILLING CODE 3290–F0–P DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration Qualification of Drivers; Exemption Applications; Hearing Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation (DOT). ACTION: Notice of final disposition. AGENCY: FMCSA announces its decision to renew exemptions for nine individuals from the hearing requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) for interstate commercial motor vehicle (CMV) drivers. The exemptions enable these hard of hearing and deaf individuals to continue to operate CMVs in interstate commerce. PO 00000 Frm 00101 Fmt 4703 Sfmt 4703 Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64–224, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Dockets Operations, (202) 366–9826. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: I. Public Participation A. Viewing Comments To view comments go to https:// www.regulations.gov. Insert the docket number, FMCSA–2012–0154, FMCSA– 2014–0106, FMCSA–2014–0384, FMCSA–2015–032, FMCSA–2017–0057, or FMCSA–2018–0136 in the keyword box, and click ‘‘Search.’’ Next, sort the results by ‘‘Posted (Newer-Older),’’ choose the first notice listed, and click ‘‘Browse Comments.’’ If you do not have access to the internet, you may view the docket online by visiting Dockets Operations in Room W12–140 on the ground floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590–0001, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays. To be sure someone is there to help you, please call (202) 366–9317 or (202) 366– 9826 before visiting Dockets Operations. B. Privacy Act [Docket No. FMCSA–2012–0154; FMCSA– 2014–0106; FMCSA–2014–0384; FMCSA– 2015–0328; FMCSA–2017–0057; FMCSA– 2018–0136] SUMMARY: Each group of renewed exemptions were applicable on the dates stated in the discussions below and will expire on the dates provided below. DATES: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL– 14 FDMS), which can be reviewed at www.transportation.gov/privacy. II. Background On January 15, 2021, FMCSA published a notice announcing its decision to renew exemptions for nine individuals from the hearing standard in 49 CFR 391.41(b)(11) to operate a CMV in interstate commerce and requested comments from the public (86 FR 4175). The public comment period ended on February 16, 2021, and one comment was received. E:\FR\FM\10MRN1.SGM 10MRN1

Agencies

Office of the United States Trade Representative

[Federal Register Volume 86, Number 45 (Wednesday, March 10, 2021)]
[Notices]
[Pages 13785-13786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04946]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE


Notice of Product Exclusion Extensions: China's Acts, Policies, 
and Practices Related to Technology Transfer, Intellectual Property, 
and Innovation

AGENCY: Office of the United States Trade Representative (USTR).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In prior notices, the U.S. Trade Representative modified the 
action in the Section 301 investigation of China's acts, policies, and 
practices related to technology transfer, intellectual property, and 
innovation by excluding from additional duties certain medical-care 
products needed to address the COVID-19 pandemic. To support efforts to 
combat COVID-19, on December 29, 2020, the U.S. Trade Representative 
announced the extension of certain product exclusions on medical-care 
and/or COVID response products and further modifications to remove 
Section 301 duties from additional medical-care and/or COVID response 
products. This notice announces the U.S. Trade Representative's 
determination to extend those exclusions.

[[Page 13786]]


DATES: The extensions announced in this notice will extend the product 
exclusions through September 30, 2021. U.S. Customs and Border 
Protection will issue instructions on entry guidance and 
implementation.

FOR FURTHER INFORMATION CONTACT: For general questions about this 
notice, contact Associate General Counsel Philip Butler, Assistant 
General Counsels Benjamin Allen or Susie Park Hodge, or Director of 
Industrial Goods Justin Hoffmann at (202) 395-5725. For specific 
questions on customs classification or implementation of the product 
exclusions identified in the Annexes to this notice, contact 
[email protected].

SUPPLEMENTARY INFORMATION:

A. Background

    In the course of this investigation the U.S. Trade Representative 
has imposed additional duties on products of China in four tranches. 
See 83 FR 28719 (June 20, 2018); 83 FR 40823 (August 16, 2018); 83 FR 
47974 (September 21, 2018), as modified by 83 FR 49153 (September 28, 
2018); and 84 FR 43304 (August 20, 2019), as modified by 84 FR 69447 
(December 18, 2019) and 85 FR 3741 (January 22, 2020).
    For each tranche, the U.S. Trade Representative established a 
process by which U.S. stakeholders could request the exclusion of 
particular products subject to the action. The U.S. Trade 
Representative later established a process by which U.S. stakeholders 
could request the extension of particular exclusions. Additionally, on 
March 25, 2020, the U.S. Trade Representative requested public comments 
on possible further modifications to remove Section 301 duties from 
additional medical-care products to address the COVID-19 pandemic. 85 
FR 16987 (March 25, 2020).
    In light of the evolving nature of the battle against COVID-19, on 
December 29, 2020, USTR announced the extension of 80 product 
exclusions on medical-care and/or COVID response products; further 
modifications in the form of 19 product exclusions to remove Section 
301 duties from additional medical-care and/or COVID response products; 
and that USTR might consider further extensions and/or modifications as 
appropriate. See 85 FR 85831 (the December 29 notice).

B. Determination To Extend Certain Exclusions

    In light of the continuing efforts to combat COVID-19, the U.S. 
Trade Representative has determined that it is inappropriate to allow 
the exclusions for certain products to lapse. Accordingly, pursuant to 
sections 301(b), 301(c), and 307(a) of the Trade Act of 1974, as 
amended, the U.S. Trade Representative has determined to extend the 99 
product exclusions included in the December 29 notice through September 
30, 2021, as specified in the Annex to this notice. The U.S. Trade 
Representative's decision to extend the 99 product exclusions takes 
into account public comments previously provided, and the advice of 
advisory committees the interagency Section 301 Committee.
    As provided in the December 29 notice, the exclusions are available 
for any product that meets the description in the product exclusion. 
The U.S. Trade Representative may continue to consider further 
extensions and/or additional modifications as appropriate.

Annex

    Effective with respect to goods entered for consumption, or 
withdrawn from warehouse for consumption, on or after 12:01 a.m. 
eastern daylight time on April 1, 2021, and before 11:59 p.m. 
eastern daylight time on September 30, 2021, each of the article 
descriptions of headings 9903.88.62, 9903.88.63, 9903.88.64 and 
9903.88.65 of the Harmonized Tariff Schedule of the United States 
are modified by deleting ``March 31, 2021,'' and by inserting 
``September 30, 2021,'' in lieu thereof.

Greta Peisch,
General Counsel, Office of the United States Trade Representative.
[FR Doc. 2021-04946 Filed 3-9-21; 8:45 am]
BILLING CODE 3290-F0-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.